93 related articles for article (PubMed ID: 10630231)
1. [Terminal care of cancer patients using an implanted venous reservoir].
Nakamura S
Gan To Kagaku Ryoho; 1999 Dec; 26 Suppl 2():273-6. PubMed ID: 10630231
[TBL] [Abstract][Full Text] [Related]
2. [Experience with implanted venous reservoirs in patients with terminal urological cancers].
Yokoyama M; Nakanishi Y; Arisawa C; Ando M
Hinyokika Kiyo; 2007 Mar; 53(3):153-6. PubMed ID: 17447482
[TBL] [Abstract][Full Text] [Related]
3. A comparative study between two central veins for the introduction of totally implantable venous access devices in 1201 cancer patients.
Araújo C; Silva JP; Antunes P; Fernandes JM; Dias C; Pereira H; Dias T; Fougo JL
Eur J Surg Oncol; 2008 Feb; 34(2):222-6. PubMed ID: 17566692
[TBL] [Abstract][Full Text] [Related]
4. [Complications after insertion of a totally implantable venous access port in patients treated with chemotherapy for head and neck squamous cell carcinoma].
Hoareau-Gruchet F; Rtail R; Sulaj H; Khirnetkina A; Reyt E; Righini CA
Ann Otolaryngol Chir Cervicofac; 2009 Apr; 126(2):43-52. PubMed ID: 19324328
[TBL] [Abstract][Full Text] [Related]
5. External jugular Groshong catheter is associated with fewer complications than a subclavian Argyle catheter.
Ishizuka M; Nagata H; Takagi K; Horie T; Furihata M; Nakagawa A; Kubota K
Eur Surg Res; 2008; 40(2):197-202. PubMed ID: 17998779
[TBL] [Abstract][Full Text] [Related]
6. [Safety and effectiveness of central vein catheters indwelling with subcutaneous port in patients undergoing chemotherapy].
Ge F; Cang J; Xue ZG
Zhonghua Yi Xue Za Zhi; 2008 Aug; 88(33):2331-4. PubMed ID: 19087693
[TBL] [Abstract][Full Text] [Related]
7. [Totally implantable vascular reservoir for chemotherapy: initial experience].
Cutait R; Averbach M; Borges JL; Carone E; Correa PA
AMB Rev Assoc Med Bras; 1990; 36(2):97-9. PubMed ID: 1965673
[TBL] [Abstract][Full Text] [Related]
8. [Encapsulated implantable venous access device: two clinical cases].
Guivarch E; Kriegel I; Bonnet L; di Maria S; Estève M
Ann Fr Anesth Reanim; 2009 Mar; 28(3):238-41. PubMed ID: 19327941
[TBL] [Abstract][Full Text] [Related]
9. Do central venous catheters have advantages over arteriovenous fistulas or grafts?
Quarello F; Forneris G; Borca M; Pozzato M
J Nephrol; 2006; 19(3):265-79. PubMed ID: 16874685
[TBL] [Abstract][Full Text] [Related]
10. [A fully implantable port system for venous access. Personal experience with 91 patients].
Zák P; Tauchman M; Maisnar V; Podzimek K; Mirová S; Voglová J; Dulícek P; Filip S; Chrobák L
Vnitr Lek; 1997 May; 43(5):273-8. PubMed ID: 9601848
[TBL] [Abstract][Full Text] [Related]
11. [Experience with the Groshong port in a home TPN patient--a case report].
Inoue Y; Soh H; Nakamura T; Komoda H; Hoki M; Honda M; Sunada S; Takao T
Gan To Kagaku Ryoho; 1995 Dec; 22 Suppl 4():378-83. PubMed ID: 8849279
[TBL] [Abstract][Full Text] [Related]
12. [Injection ports or implanted catheter device].
Hainez E
Rev Infirm; 2011 Apr; (170):45-6. PubMed ID: 21548352
[No Abstract] [Full Text] [Related]
13. Comparisons of outcomes and survivals for two central venous access port systems.
Hou SM; Wang PC; Sung YC; Lee HH; Liu HT; Chen YH
J Surg Oncol; 2005 Jul; 91(1):61-6. PubMed ID: 15999349
[TBL] [Abstract][Full Text] [Related]
14. Cathlink 20: a subcutaneous implanted central venous access device used in children with sickle cell disease on long-term erythrocytapheresis--a report of low complication rates.
Raj A; Bertolone S; Bond S; Burnett D; Denker A
Pediatr Blood Cancer; 2005 Jun; 44(7):669-72. PubMed ID: 15700248
[TBL] [Abstract][Full Text] [Related]
15. Complications and cost associated with parenteral nutrition delivered to hospitalized patients through either subclavian or peripherally-inserted central catheters.
Cowl CT; Weinstock JV; Al-Jurf A; Ephgrave K; Murray JA; Dillon K
Clin Nutr; 2000 Aug; 19(4):237-43. PubMed ID: 10952794
[TBL] [Abstract][Full Text] [Related]
16. Port-A-Cath implantation using percutaneous puncture without guidance.
Ku YH; Kuo PH; Tsai YF; Huang WT; Lin MH; Tsao CJ
Ann Surg Oncol; 2009 Mar; 16(3):729-34. PubMed ID: 19101767
[TBL] [Abstract][Full Text] [Related]
17. [Late rupture of central catheter implanted through subclavian route].
Fernández R; Jiménez M; Vicente J; Rascado A; Gutiérrez C
Rev Esp Anestesiol Reanim; 2002 Jan; 49(1):34-6. PubMed ID: 11898445
[TBL] [Abstract][Full Text] [Related]
18. [Home anti-cancer therapy with a venous port].
Muto A; Ashino Y; Miyazawa M; Sato M; Kanno A; Kawahara Y; Fujita Y; Matsushiro T
Gan To Kagaku Ryoho; 2000 Dec; 27 Suppl 3():619-22. PubMed ID: 11190304
[TBL] [Abstract][Full Text] [Related]
19. [Insertion and removal of an implanted catheter].
Bonnichon P; Molinier N
Soins; 1999 Nov; (640 Suppl):5-6. PubMed ID: 10948963
[No Abstract] [Full Text] [Related]
20. A prospective randomized trial demonstrating valved implantable ports have fewer complications and lower overall cost than nonvalved implantable ports.
Carlo JT; Lamont JP; McCarty TM; Livingston S; Kuhn JA
Am J Surg; 2004 Dec; 188(6):722-7. PubMed ID: 15619490
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
